Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 18, 2016BloodOpen Access

Follicular lymphoma: evolving therapeutic strategies

View Full Paper
Ask AI
Bookmark
Share

Authors

BKBrad S. KahlBarnes-Jewish HospitalDYDavid T. YangUniversity of Wisconsin–Madison

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kahl et al. (2016) studied this question.

synapsesocial.com/papers/69d8d117183921ebcaae3c32https://doi.org/10.1182/blood-2015-11-624288
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Pathogenesis of follicular lymphoma2012 · 315 citations
  2. 2Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma2003 · 364 citations
  3. 3Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS)2015 · 222 citations
  4. 4Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study2015 · 866 citations
  5. 5Rituximab Extended Schedule or Re-Treatment Trial for Low–Tumor Burden Follicular Lymphoma: Eastern Cooperative Oncology Group Protocol E44022014 · 195 citations